Chugai Pharmaceutical Co. Ltd. - Research and Development

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Research-and-Development" stands at 187.42 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of 48.60 Billion JPY for the item "Research and Development" represents an increase of 6.43 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of 48.60 Billion JPY for the item "Research and Development" represents an increase of 8.19 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of 187.42 Billion JPY for the item "Research and Development" represents an increase of 2.00 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.61 percent compared to the value the year prior.
The 1 year change in percent is 9.61.
The 3 year change in percent is 36.00.
The 5 year change in percent is 61.75.
The 10 year change in percent is 117.96.

The Serie's long term average value is 108.52 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 72.71 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2012, to it's latest available value, on 09/30/2025, is +242.85%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.